Home / Medical Devices / Seborrheic Keratosis Treatment Market By Treatment Type (Surgical Treatment, Topical Solution Treatment) - Growth, Share, Opportunities & Competitive Analysis, 2018 -2026

Seborrheic Keratosis Treatment Market By Treatment Type (Surgical Treatment, Topical Solution Treatment) - Growth, Share, Opportunities & Competitive Analysis, 2018 -2026

Published: Apr 2018 | Report Code: 59075-04-18

Market Excerpt

The global seborrheic keratosis (SK) treatment expected to reach US$ 1,320.8 Mn by 2026. Growing preference for cosmetic and aesthetic quotient and high prevalence of seborrheic keratosis are observed to be the key factors driving the seborrheic keratosis treatment market. This market is further characterized by the presence of a multitude of players operating in various treatment modules such as laser, cryosurgery, surgical removal etc. In addition, with promising topical candidates in the pipeline, the seborrheic keratosis treatment market will witness a boost in future growth.

According to an article published by Jackson JM et.al in 2015 (Jackson JM et.al. Current Understanding of Seborrheic Keratosis: Prevalence, Etiology, Clinical Presentation, Diagnosis, and Management, J Drugs Dermatol; 2015 Oct; 14(10):1119-25.), an estimated of 83 million people were affected by seborrheic keratosis in 2014 and dermatologists reported an average diagnosis of 155 patients per month with the disease in the United States. Of these patients, 33% had over 15 lesions and 67% had 15 or lesser lesions. In addition, with the surge in geriatric population, the eligible patient pool for SK treatment further expands, thus driving the overall market growth. Furthermore, it was estimated that around 43% of the patients opt for the surgical treatment due to benign and less painful nature of the growth. Additionally, lack of reimbursement policies in developed as well as developing countries for the treatment hinders the market growth. Reimbursement is considered for seborrheic keratosis treatment only in cases of bleeding, itching and other medical reasons, and not for cosmetic treatments. Manufacturers are investing in research and development for the non-invasive and non-surgical treatment methods for seborrheic keratosis. For instance, in 2017, a topical solution - Eskata, 40% hydrogen peroxide, was approved for the treatment.

Market Synopsis

Seborrheic Keratosis Treatment Market

Approval of topical solutions will drive the market during the forecast period

Several topical solutions are used as off-label therapeutics to reduce the height of the seborrheic keratosis including ammonium lactate and alpha hydroxy acids among others. However, in 2017, the FDA approved hydrogen peroxide (40% solution), branded as Eskata developed by Aclaris Therapeutics, Inc. for the treatment of seborrheic keratosis. The product will be available in the United States after its expected commercialization in the first half of 2018. A few other topical solutions are currently in pipeline, which are expected to be approved within the forecast period. Development of cost-effective and non-surgical treatment options are anticipated to drive the market coupled with the rising awareness in the patient population.

Cryosurgery is the most preferred treatment for seborrheic keratosis, followed by other surgical treatment options such as electrocautery, curettage etc. With the adoption of laser treatment methods, the market for seborrheic keratosis treatments will experience an upsurge. In 2017, cryosurgery segment led the market in terms of market value and will retain its lead during the forecast period. High preference by physicians due to significant treatment outcomes mainly contribute to the dominance of this segment. Demand for topical solution treatment (Eskata) as a viable treatment option in the market, after its commercialization in 2018, significantly contribute to the market growth.

Seborrheic Keratosis Treatment Market

Asia Pacific to experience lucrative growth during the forecast period

Asia Pacific is expected to experience the fastest market growth during the forecast period owing to growing prevalence of SK and increasing adoption of surgical treatment in the region. Since there is no clarity on commercialization of Eskata (40% hydrogen peroxide) in the region, other treatment segments in the region will not face any substantial competition. In 2017, North America dominated the global seborrheic keratosis market owing to the adoption of advanced treatment options and awareness of the disease. Additionally, a majority of the players are headquartered in the United States, which further contributes to the supremacy of North America. In terms of market value, North America was followed by Europe in 2017. In Europe, it has been estimated that over 90% of adults aged over 60 or more have at least one or more SK lesions. Approximately 40%-60% of the entire population in Europe has at least one SK lesion. Northern Europe has a higher prevalence of seborrheic keratosis.

Seborrheic Keratosis Treatment Market

Cryosurgery devices are among the major revenue contributors to the manufacturers

Although several options are available in the market for seborrheic keratosis treatment, cryosurgery is the most preferred treatment method due to proven better treatment outcomes. Preference as viable treatment method coupled with high prevalence resulted in growing installation of cryosurgery devices in the United States and other developed countries. Furthermore, players are investing in introduction of cost-effective and non-surgical treatment of the disease. For instance, EpiPharm AG, a Switzerland based company, is investing in new and non-invasive therapies for the treatment of benign skin tumors. EPI-SK14, pipeline product, of EpiPharm is in Phase II clinical trials and is a non-invasive treatment for seborrheic keratosis. Furthermore, manufacturers have diverse product portfolio, which satisfies the growing demand of the disease burden.

Seborrheic Keratosis Treatment Market

Historical & Forecast Period

2016 – Historical Year

2017 – Base Year

2018-2026 – Forecast Period

Each segment is analyzed from 2016 to 2026 considering 2017 as the base year for the study. Compound Annual Growth Rate (CAGR) are calculated for the forecast period from 2018 to 2026 for each segment.

Report Scope by Segments

This report on seborrheic keratosis treatment market presents market outlook along with quantitative research of the global trends. The report provides detailed outline of the global seborrheic keratosis treatment market by categorizing the market in terms of treatment type and geography. The objective of publishing this extensive research report is to aid the stakeholders in making decisions and strategic initiatives in the seborrheic keratosis treatment market.

Treatment Type Segment (2016–2026; US$ Mn)

  • Surgical Treatment
    • Cryosurgery
    • Electrocautery
    • Curettage
    • Laser Ablation
  • Topical Solution Treatment

Geography Segment (2016–2026; US$ Mn)

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • Rest of Europe
  • Asia Pacific (APAC)
  • Japan
  • China
  • Rest of APAC
  • Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East and Africa (MEA)
  • GCC
  • Rest of MEA

Seborrheic Keratosis Treatment Market

This report further describes the major qualitative assessment factors including key market trends, market drivers & restraints, to aid in better understanding of global seborrheic keratosis treatment market. Furthermore, the key players are graphically mapped based on their product offering, market strategies and business strength. The report also provides attractive investment proposition based on the extensive geographical research. Key players profiled in the report include Aclaris Therapeutics, Inc., Cortex Technology ApS, CryoConcepts LP, Cryoswiss GmbH, EpiPharm AG, H&O Equipments SA, Orasure Technologies, Inc., Special Medical Technology Co., Ltd., and Wallach Surgical Devices, Inc.

Key questions answered in this report

  • Which are the prominent segments in seborrheic keratosis treatment?
  • What will be the effect of topical solution approval by FDA on global market?
  • What are the current market trends in the seborrheic keratosis treatment industry and valuable growth opportunities for the players?
  • Which prominent geographies are appropriate for product launch?
  • Which segment is the fastest growing segment during the forecast period?
  • What is the size of North America seborrheic keratosis treatment market, and how the other regional markets stand in the global competition?

Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I - Secondary Research
1.4.2. Phase II - Primary Research
1.4.3. Phase III - Expert Panel Review
1.4.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Seborrheic Keratosis Treatment Market Portraiture
2.2. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2017 (US$ Mn)
2.3. Global Seborrheic Keratosis Treatment Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Seborrheic Keratosis Treatment Market: Market Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Prevalence of Seborrheic Keratosis
3.2.1.2. Driver 2
3.2.2. Challenges
3.2.2.1. Challenge 1
3.2.2.2. Challenge 2
3.2.3. Opportunities
3.2.3.1. Opportunity 1
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Surgical Treatment
4.2.1. Cryosurgery
4.2.2. Electrocautery
4.2.3. Curettage
4.2.4. Laser Ablation
4.3. Topical Solution Treatment
4.3.1. Hydrogen Peroxide 40% Solution (Eskata)
4.4. Pipeline Drugs (Qualitative Information)
4.4.1. EPI SK14 (EpiPharm AG)

Chapter 5. Global Seborrheic Keratosis Treatment Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. North America Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.2.1. North America Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.2.2. North America Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.3.1. Europe Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.3.2. Europe Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.4.1. Asia Pacific Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.4.2. Asia Pacific Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of APAC
5.5. Latin America Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.5.1. Latin America Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.5.2. Latin America Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.6.1. Middle East & Africa Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.6.2. Middle East & Africa Seborrheic Keratosis Treatment Market, by Region, 2016 - 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Aclaris Therapeutics, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Cortex Technology ApS
6.3. CryoConcepts LP
6.4. Cryoswiss GmbH
6.5. DRE Medical, Inc.
6.6. EpiPharm AG
6.7. H&O Equipments SA
6.8. Orasure Technologies, Inc.
6.9. Special Medical Technology Co., Ltd.
6.10. Wallach Surgical Devices, Inc.

FIG. 1 Market Segmentation: Global Seborrheic Keratosis Treatment Market
FIG. 2 Research Methodology: Global Seborrheic Keratosis Treatment Market
FIG. 3 Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2017 (US$ Mn)
FIG. 4 Global Seborrheic Keratosis Treatment Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: Global Seborrheic Keratosis Treatment Market, by Geography, 2017
FIG. 6 Competitive Landscape, by Key Players, 2017
FIG. 7 Global Cryosurgery Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 8 Global Electrocautery Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 9 Global Curettage Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 10 Global Laser Ablation Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 11 Global Hydrogen Peroxide 40% Solution (Eskata) Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 12 U.S. Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 13 Canada Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 14 U.K. Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 15 Germany Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 16 Rest of Europe Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 17 Japan Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 18 China Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 19 Rest of Asia Pacific Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 20 Brazil Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 21 Mexico Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 22 Rest of Latin America Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 23 GCC Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 24 Rest of Middle East and Africa Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)

TABLE 1. Global Seborrheic Keratosis Treatment Market Portraiture
TABLE 2. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
TABLE 3. Global Seborrheic Keratosis Treatment Market, by Geography, 2016 - 2026 (US$ Mn)
TABLE 4. Global Surgical Treatments Market for Seborrheic Keratosis, by Type, 2016 - 2026 (US$ Mn)
TABLE 5. Global Topical Solution Market for Seborrheic Keratosis Treatment, by Type, 2016 - 2026 (US$ Mn)
TABLE 6. North America Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
TABLE 7. North America Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 8. Europe Seborrheic Keratosis Treatment Market, by Type, 2016 - 2026 (US$ Mn)
TABLE 9. Europe Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 10. Asia Pacific Seborrheic Keratosis Treatment Market, by Type, 2016 - 2026 (US$ Mn)
TABLE 11. Asia Pacific Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 12. Latin America Seborrheic Keratosis Treatment Market, by Type, 2016 - 2026 (US$ Mn)
TABLE 13. Latin America Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 14. Middle East and Africa Seborrheic Keratosis Treatment Market, by Type, 2016 - 2026 (US$ Mn)
TABLE 15. Middle East and Africa Seborrheic Keratosis Treatment Market, by Region, 2016 - 2026 (US$ Mn)
TABLE 16. Aclaris Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17. Cortex Technology ApS: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18. CryoConcepts LP.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19. Cryoswiss GmbH.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20. DRE Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21. EpiPharm AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22. H&O Equipments SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23. Orasure Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24. Special Medical Technology Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25. Wallach Surgical Devices, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients